Mindray Medical Forms Special Committee To Consider Going Private Transaction

(RTTNews) - Mindray Medical International Limited (MR) announced its board has formed a special committee comprised of three independent directors to consider the previously announced non-binding proposal from Li Xiting, its Executive Chairman of the Board, President and Co-CEO, Xu Hang, Chairman of the Board, and Cheng Minghe, its Co-CEO and Chief Strategic Officer. The proposal contemplates the buyer Group acquiring outstanding ordinary shares of Mindray Medical in a going private transaction at a price of $30.00 in cash per ordinary share or ADS.

The Special Committee has retained Lazard Asia (Hong Kong) as its independent financial advisor and Shearman & Sterling as its U.S. legal counsel to assist it in its evaluation of the proposal and any other alternative transaction.